Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOXM1
|
ENSG00000111206.8 | forkhead box M1 |
TBL1XR1
|
ENSG00000177565.11 | TBL1X receptor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_2985846_2986175 | FOXM1 | 97 | 0.782284 | -0.75 | 1.9e-02 | Click! |
chr12_2985657_2985808 | FOXM1 | 375 | 0.589938 | -0.61 | 7.8e-02 | Click! |
chr12_2977204_2977355 | FOXM1 | 468 | 0.671293 | -0.19 | 6.3e-01 | Click! |
chr12_2985389_2985640 | FOXM1 | 593 | 0.460401 | -0.18 | 6.4e-01 | Click! |
chr3_177063284_177063501 | TBL1XR1 | 148131 | 0.043343 | -0.93 | 2.2e-04 | Click! |
chr3_176914402_176914710 | TBL1XR1 | 284 | 0.940844 | -0.83 | 5.9e-03 | Click! |
chr3_176896271_176896422 | TBL1XR1 | 17865 | 0.226059 | -0.68 | 4.4e-02 | Click! |
chr3_176913375_176914206 | TBL1XR1 | 421 | 0.893131 | -0.64 | 6.2e-02 | Click! |
chr3_177040689_177040840 | TBL1XR1 | 125503 | 0.057162 | -0.55 | 1.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_113932374_113933030 | 1.80 |
RP11-553L6.2 |
|
458 |
0.8 |
chr19_14260226_14260973 | 1.77 |
LPHN1 |
latrophilin 1 |
3052 |
0.14 |
chr3_114170562_114171054 | 1.73 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
2722 |
0.36 |
chr1_159823893_159825316 | 1.65 |
C1orf204 |
chromosome 1 open reading frame 204 |
533 |
0.6 |
chr17_53342049_53343259 | 1.62 |
HLF |
hepatic leukemia factor |
281 |
0.93 |
chr7_19155354_19155672 | 1.60 |
TWIST1 |
twist family bHLH transcription factor 1 |
1782 |
0.28 |
chr4_121737778_121738146 | 1.57 |
ENSG00000212359 |
. |
6338 |
0.32 |
chr8_116660172_116660961 | 1.45 |
TRPS1 |
trichorhinophalangeal syndrome I |
13339 |
0.31 |
chr5_42756888_42757786 | 1.43 |
CCDC152 |
coiled-coil domain containing 152 |
417 |
0.88 |
chrX_101186111_101187162 | 1.41 |
ZMAT1 |
zinc finger, matrin-type 1 |
101 |
0.97 |
chr11_12529707_12530128 | 1.41 |
PARVA |
parvin, alpha |
55635 |
0.15 |
chr4_71587677_71588145 | 1.35 |
RUFY3 |
RUN and FYVE domain containing 3 |
183 |
0.92 |
chr17_29335129_29336577 | 1.35 |
RP11-848P1.9 |
|
81 |
0.95 |
chr8_58660875_58661197 | 1.31 |
ENSG00000252057 |
. |
191892 |
0.03 |
chr10_63813971_63814567 | 1.29 |
ARID5B |
AT rich interactive domain 5B (MRF1-like) |
5299 |
0.3 |
chr8_21770420_21771232 | 1.24 |
DOK2 |
docking protein 2, 56kDa |
348 |
0.88 |
chr15_86162614_86163207 | 1.23 |
RP11-815J21.3 |
|
8010 |
0.15 |
chr15_36890741_36891034 | 1.23 |
C15orf41 |
chromosome 15 open reading frame 41 |
3786 |
0.35 |
chrX_69674453_69675874 | 1.22 |
DLG3 |
discs, large homolog 3 (Drosophila) |
217 |
0.75 |
chr2_188236807_188237304 | 1.21 |
CALCRL |
calcitonin receptor-like |
75924 |
0.11 |
chr10_4015020_4015405 | 1.21 |
KLF6 |
Kruppel-like factor 6 |
187739 |
0.03 |
chr13_51466419_51466869 | 1.18 |
RNASEH2B-AS1 |
RNASEH2B antisense RNA 1 |
866 |
0.61 |
chr12_7037386_7038830 | 1.17 |
ATN1 |
atrophin 1 |
632 |
0.41 |
chr8_93113958_93114847 | 1.16 |
RUNX1T1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
1052 |
0.69 |
chr13_58205325_58205914 | 1.16 |
PCDH17 |
protocadherin 17 |
1036 |
0.71 |
chr13_24807615_24808021 | 1.16 |
SPATA13 |
spermatogenesis associated 13 |
18014 |
0.17 |
chr14_99736204_99736825 | 1.15 |
BCL11B |
B-cell CLL/lymphoma 11B (zinc finger protein) |
1051 |
0.56 |
chr6_16421411_16421759 | 1.15 |
ENSG00000265642 |
. |
7169 |
0.31 |
chrX_100672866_100673966 | 1.14 |
ENSG00000221132 |
. |
9067 |
0.11 |
chr7_79820122_79820273 | 1.14 |
GNAI1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
3822 |
0.32 |
chr2_223159902_223160949 | 1.12 |
CCDC140 |
coiled-coil domain containing 140 |
2441 |
0.27 |
chr6_148829582_148830289 | 1.12 |
ENSG00000223322 |
. |
15441 |
0.29 |
chrX_107018688_107019917 | 1.12 |
TSC22D3 |
TSC22 domain family, member 3 |
43 |
0.97 |
chr14_24803093_24804202 | 1.11 |
ADCY4 |
adenylate cyclase 4 |
306 |
0.72 |
chr12_111843881_111845308 | 1.11 |
SH2B3 |
SH2B adaptor protein 3 |
842 |
0.62 |
chr18_70210992_70211675 | 1.11 |
CBLN2 |
cerebellin 2 precursor |
441 |
0.91 |
chr1_50889793_50890319 | 1.09 |
DMRTA2 |
DMRT-like family A2 |
884 |
0.66 |
chr8_116675821_116675972 | 1.07 |
TRPS1 |
trichorhinophalangeal syndrome I |
1991 |
0.5 |
chr11_104669483_104669764 | 1.07 |
CASP12 |
caspase 12 (gene/pseudogene) |
99518 |
0.08 |
chrX_130036036_130037401 | 1.07 |
ENOX2 |
ecto-NOX disulfide-thiol exchanger 2 |
460 |
0.9 |
chr3_105844850_105845167 | 1.06 |
CBLB |
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
256612 |
0.02 |
chr7_55546043_55546306 | 1.06 |
VOPP1 |
vesicular, overexpressed in cancer, prosurvival protein 1 |
37596 |
0.19 |
chr17_46689926_46690387 | 1.06 |
HOXB8 |
homeobox B8 |
685 |
0.39 |
chr3_191008696_191008913 | 1.06 |
UTS2B |
urotensin 2B |
8612 |
0.23 |
chr3_59101698_59102091 | 1.03 |
C3orf67 |
chromosome 3 open reading frame 67 |
66084 |
0.15 |
chr15_32963693_32963946 | 1.02 |
RP11-1000B6.2 |
|
1447 |
0.36 |
chr11_75272983_75274329 | 1.02 |
SERPINH1 |
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
216 |
0.91 |
chr1_204547968_204548318 | 1.01 |
ENSG00000200408 |
. |
16494 |
0.15 |
chr20_25291380_25291730 | 1.01 |
ABHD12 |
abhydrolase domain containing 12 |
1421 |
0.44 |
chr2_118981129_118982486 | 1.01 |
INSIG2 |
insulin induced gene 2 |
135757 |
0.05 |
chr18_11175685_11175836 | 1.00 |
PIEZO2 |
piezo-type mechanosensitive ion channel component 2 |
27173 |
0.27 |
chr6_94494975_94495370 | 1.00 |
ENSG00000252249 |
. |
93652 |
0.1 |
chrX_34673939_34674563 | 0.99 |
TMEM47 |
transmembrane protein 47 |
1154 |
0.68 |
chr1_8570200_8570964 | 0.99 |
ENSG00000221083 |
. |
1396 |
0.47 |
chr2_183755742_183755893 | 0.99 |
ENSG00000207178 |
. |
17248 |
0.19 |
chr17_2118811_2119625 | 0.99 |
AC130689.5 |
|
91 |
0.93 |
chr10_104813584_104814284 | 0.98 |
NT5C2 |
5'-nucleotidase, cytosolic II |
40191 |
0.17 |
chr6_19838575_19839711 | 0.98 |
RP1-167F1.2 |
|
168 |
0.95 |
chr18_32609618_32610414 | 0.97 |
MAPRE2 |
microtubule-associated protein, RP/EB family, member 2 |
11308 |
0.29 |
chrX_92186307_92186458 | 0.97 |
ENSG00000211526 |
. |
470931 |
0.01 |
chr12_6901564_6902297 | 0.97 |
CD4 |
CD4 molecule |
3196 |
0.1 |
chr7_54972295_54972520 | 0.97 |
ENSG00000252054 |
. |
38896 |
0.2 |
chr1_57042434_57042715 | 0.96 |
PPAP2B |
phosphatidic acid phosphatase type 2B |
2667 |
0.39 |
chr6_155492736_155493156 | 0.95 |
TIAM2 |
T-cell lymphoma invasion and metastasis 2 |
22691 |
0.23 |
chr2_40986410_40986561 | 0.95 |
SLC8A1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
148292 |
0.05 |
chr19_49377380_49378153 | 0.95 |
PPP1R15A |
protein phosphatase 1, regulatory subunit 15A |
191 |
0.87 |
chr4_71940368_71940554 | 0.95 |
DCK |
deoxycytidine kinase |
81106 |
0.1 |
chr2_18595221_18595519 | 0.95 |
RDH14 |
retinol dehydrogenase 14 (all-trans/9-cis/11-cis) |
146576 |
0.04 |
chr2_238315058_238315400 | 0.94 |
COL6A3 |
collagen, type VI, alpha 3 |
7562 |
0.22 |
chr10_114135452_114136486 | 0.93 |
ACSL5 |
acyl-CoA synthetase long-chain family member 5 |
12 |
0.98 |
chrX_95690881_95691032 | 0.93 |
ENSG00000223260 |
. |
25175 |
0.28 |
chr20_30358146_30358468 | 0.93 |
TPX2 |
TPX2, microtubule-associated |
31233 |
0.11 |
chr6_33587944_33588935 | 0.93 |
ITPR3 |
inositol 1,4,5-trisphosphate receptor, type 3 |
297 |
0.87 |
chr3_71038413_71038564 | 0.93 |
FOXP1 |
forkhead box P1 |
75589 |
0.12 |
chr6_137442626_137442884 | 0.92 |
IL22RA2 |
interleukin 22 receptor, alpha 2 |
52030 |
0.14 |
chr22_29601932_29602692 | 0.92 |
EMID1 |
EMI domain containing 1 |
400 |
0.8 |
chr19_48085573_48085724 | 0.92 |
ENSG00000264280 |
. |
1368 |
0.35 |
chr2_32893445_32893596 | 0.92 |
TTC27 |
tetratricopeptide repeat domain 27 |
10425 |
0.24 |
chr10_27148230_27149879 | 0.92 |
ABI1 |
abl-interactor 1 |
738 |
0.67 |
chr3_12436703_12437398 | 0.92 |
PPARG |
peroxisome proliferator-activated receptor gamma |
44079 |
0.15 |
chr18_53067346_53067650 | 0.91 |
TCF4 |
transcription factor 4 |
1068 |
0.61 |
chrX_15800485_15800703 | 0.91 |
ZRSR2 |
zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2 |
8001 |
0.2 |
chr5_71920063_71920214 | 0.91 |
ZNF366 |
zinc finger protein 366 |
116584 |
0.06 |
chr4_114680711_114680982 | 0.91 |
CAMK2D |
calcium/calmodulin-dependent protein kinase II delta |
1378 |
0.6 |
chr19_10982465_10983821 | 0.91 |
CARM1 |
coactivator-associated arginine methyltransferase 1 |
764 |
0.53 |
chr19_14480990_14481300 | 0.90 |
CD97 |
CD97 molecule |
10823 |
0.15 |
chr12_50748152_50748528 | 0.90 |
FAM186A |
family with sequence similarity 186, member A |
3672 |
0.22 |
chr10_90761012_90761338 | 0.90 |
ACTA2 |
actin, alpha 2, smooth muscle, aorta |
10028 |
0.14 |
chr13_24844888_24845461 | 0.90 |
SPATA13 |
spermatogenesis associated 13 |
195 |
0.94 |
chr7_93925603_93925840 | 0.90 |
COL1A2 |
collagen, type I, alpha 2 |
98152 |
0.08 |
chr12_130764759_130765045 | 0.90 |
PIWIL1 |
piwi-like RNA-mediated gene silencing 1 |
57530 |
0.16 |
chr20_35643588_35643790 | 0.90 |
RBL1 |
retinoblastoma-like 1 (p107) |
52769 |
0.13 |
chr12_47608796_47608973 | 0.89 |
PCED1B |
PC-esterase domain containing 1B |
1168 |
0.54 |
chr11_94829276_94829597 | 0.89 |
ENDOD1 |
endonuclease domain containing 1 |
6462 |
0.24 |
chr4_41178199_41178352 | 0.89 |
APBB2 |
amyloid beta (A4) precursor protein-binding, family B, member 2 |
38200 |
0.15 |
chr12_131364699_131365309 | 0.89 |
RAN |
RAN, member RAS oncogene family |
8363 |
0.16 |
chr14_52329027_52329412 | 0.89 |
GNG2 |
guanine nucleotide binding protein (G protein), gamma 2 |
1177 |
0.52 |
chr5_92919468_92919846 | 0.89 |
NR2F1 |
nuclear receptor subfamily 2, group F, member 1 |
614 |
0.69 |
chr8_57471403_57471760 | 0.88 |
RP11-17A4.2 |
|
69924 |
0.12 |
chr8_51221816_51221967 | 0.88 |
RP11-759A9.1 |
|
71684 |
0.13 |
chr5_56834749_56835036 | 0.88 |
ACTBL2 |
actin, beta-like 2 |
56256 |
0.13 |
chr8_18244647_18245329 | 0.87 |
NAT2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
3767 |
0.36 |
chr15_61326296_61326540 | 0.87 |
RP11-39M21.1 |
|
147030 |
0.04 |
chr5_88171366_88171720 | 0.87 |
MEF2C |
myocyte enhancer factor 2C |
2251 |
0.36 |
chr12_74743955_74744234 | 0.86 |
ATXN7L3B |
ataxin 7-like 3B |
187457 |
0.03 |
chr5_112031090_112031241 | 0.86 |
APC |
adenomatous polyposis coli |
12030 |
0.26 |
chr4_99560865_99561052 | 0.86 |
TSPAN5 |
tetraspanin 5 |
17828 |
0.22 |
chr8_38316900_38317069 | 0.86 |
FGFR1 |
fibroblast growth factor receptor 1 |
1963 |
0.28 |
chrX_99899847_99900028 | 0.86 |
SRPX2 |
sushi-repeat containing protein, X-linked 2 |
722 |
0.65 |
chr9_128408983_128409218 | 0.86 |
MAPKAP1 |
mitogen-activated protein kinase associated protein 1 |
3596 |
0.32 |
chr13_74637272_74637666 | 0.85 |
KLF12 |
Kruppel-like factor 12 |
68283 |
0.14 |
chr19_42055859_42056077 | 0.84 |
CEACAM21 |
carcinoembryonic antigen-related cell adhesion molecule 21 |
82 |
0.97 |
chr16_80690406_80690960 | 0.84 |
ENSG00000265341 |
. |
8777 |
0.18 |
chr18_53068422_53068903 | 0.84 |
TCF4 |
transcription factor 4 |
96 |
0.98 |
chr2_152195668_152196046 | 0.84 |
TNFAIP6 |
tumor necrosis factor, alpha-induced protein 6 |
18249 |
0.16 |
chr3_197574601_197575164 | 0.84 |
LRCH3 |
leucine-rich repeats and calponin homology (CH) domain containing 3 |
10 |
0.98 |
chr6_16413526_16413976 | 0.84 |
ENSG00000265642 |
. |
15003 |
0.28 |
chr5_131745958_131747299 | 0.84 |
C5orf56 |
chromosome 5 open reading frame 56 |
45 |
0.96 |
chr16_73266288_73266597 | 0.84 |
C16orf47 |
chromosome 16 open reading frame 47 |
88096 |
0.1 |
chr11_14722182_14722400 | 0.84 |
PDE3B |
phosphodiesterase 3B, cGMP-inhibited |
56914 |
0.14 |
chr1_32268297_32268720 | 0.83 |
SPOCD1 |
SPOC domain containing 1 |
4068 |
0.18 |
chr6_154641334_154641485 | 0.83 |
IPCEF1 |
interaction protein for cytohesin exchange factors 1 |
9806 |
0.31 |
chr17_77767116_77767731 | 0.83 |
CBX8 |
chromobox homolog 8 |
3492 |
0.16 |
chr2_175187370_175187521 | 0.83 |
SP9 |
Sp9 transcription factor |
12229 |
0.16 |
chr12_105776449_105776971 | 0.83 |
C12orf75 |
chromosome 12 open reading frame 75 |
52064 |
0.13 |
chr12_88807258_88807534 | 0.83 |
ENSG00000199245 |
. |
16823 |
0.29 |
chr5_154034215_154034366 | 0.83 |
ENSG00000221552 |
. |
31046 |
0.14 |
chr2_238166258_238166409 | 0.82 |
AC112715.2 |
Uncharacterized protein |
599 |
0.83 |
chr5_158520906_158521057 | 0.82 |
EBF1 |
early B-cell factor 1 |
5720 |
0.27 |
chr11_31834234_31835305 | 0.82 |
PAX6 |
paired box 6 |
295 |
0.8 |
chr5_141980216_141980760 | 0.82 |
AC005592.2 |
|
19075 |
0.18 |
chr5_125338736_125339111 | 0.82 |
ENSG00000265637 |
. |
193605 |
0.03 |
chr12_91571050_91571576 | 0.82 |
DCN |
decorin |
1016 |
0.66 |
chr12_53599879_53600299 | 0.82 |
ITGB7 |
integrin, beta 7 |
911 |
0.42 |
chr10_6626003_6626633 | 0.82 |
PRKCQ |
protein kinase C, theta |
4055 |
0.36 |
chr17_57564845_57564996 | 0.82 |
ENSG00000200889 |
. |
49940 |
0.12 |
chr12_82760490_82760641 | 0.82 |
METTL25 |
methyltransferase like 25 |
7892 |
0.2 |
chr11_45109140_45109419 | 0.82 |
PRDM11 |
PR domain containing 11 |
6285 |
0.3 |
chr18_26761860_26762011 | 0.82 |
ENSG00000212085 |
. |
14557 |
0.28 |
chr11_95381089_95381338 | 0.82 |
FAM76B |
family with sequence similarity 76, member B |
138756 |
0.05 |
chr14_55196902_55197358 | 0.81 |
SAMD4A |
sterile alpha motif domain containing 4A |
24421 |
0.24 |
chr2_177022797_177022948 | 0.81 |
HOXD3 |
homeobox D3 |
2747 |
0.12 |
chr7_97952929_97953353 | 0.81 |
RP11-307C18.1 |
|
976 |
0.55 |
chr4_151045407_151045558 | 0.81 |
DCLK2 |
doublecortin-like kinase 2 |
45302 |
0.18 |
chr6_144471049_144472508 | 0.81 |
STX11 |
syntaxin 11 |
115 |
0.98 |
chr7_100777700_100777901 | 0.81 |
SERPINE1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
7421 |
0.1 |
chr1_86094810_86095135 | 0.80 |
ENSG00000199934 |
. |
37009 |
0.15 |
chr1_24831599_24831750 | 0.80 |
RCAN3 |
RCAN family member 3 |
2287 |
0.27 |
chr17_75663137_75663644 | 0.80 |
SEPT9 |
septin 9 |
185395 |
0.03 |
chr3_159597050_159597201 | 0.80 |
SCHIP1 |
schwannomin interacting protein 1 |
26397 |
0.18 |
chr19_13137194_13137536 | 0.80 |
NFIX |
nuclear factor I/X (CCAAT-binding transcription factor) |
1554 |
0.23 |
chr12_75874562_75875156 | 0.80 |
GLIPR1 |
GLI pathogenesis-related 1 |
125 |
0.96 |
chr20_19991582_19991882 | 0.80 |
NAA20 |
N(alpha)-acetyltransferase 20, NatB catalytic subunit |
6028 |
0.22 |
chr2_150903026_150903295 | 0.80 |
ENSG00000207270 |
. |
435872 |
0.01 |
chr18_32290517_32290846 | 0.79 |
DTNA |
dystrobrevin, alpha |
420 |
0.9 |
chr6_112080902_112081109 | 0.79 |
FYN |
FYN oncogene related to SRC, FGR, YES |
115 |
0.98 |
chr10_23216488_23217262 | 0.79 |
ARMC3 |
armadillo repeat containing 3 |
78 |
0.98 |
chr12_105114147_105114900 | 0.79 |
ENSG00000264295 |
. |
129112 |
0.05 |
chr17_65437098_65438109 | 0.79 |
ENSG00000244610 |
. |
15803 |
0.13 |
chr14_85983045_85983229 | 0.79 |
RP11-497E19.2 |
Uncharacterized protein |
11806 |
0.25 |
chr9_35276443_35276716 | 0.78 |
AL160274.1 |
HCG17281; PRO0038; Uncharacterized protein |
84683 |
0.07 |
chr4_103481434_103481585 | 0.78 |
ENSG00000238553 |
. |
5615 |
0.23 |
chr3_145874395_145874556 | 0.78 |
PLOD2 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 |
4304 |
0.27 |
chr10_88280283_88281468 | 0.78 |
WAPAL |
wings apart-like homolog (Drosophila) |
697 |
0.48 |
chr20_2731406_2732353 | 0.78 |
EBF4 |
early B-cell factor 4 |
44992 |
0.08 |
chr11_122597673_122598179 | 0.78 |
ENSG00000239079 |
. |
907 |
0.67 |
chr4_47817182_47817333 | 0.78 |
ENSG00000251827 |
. |
3605 |
0.27 |
chr4_173978999_173979247 | 0.78 |
ENSG00000241652 |
. |
83671 |
0.09 |
chr6_108943623_108943921 | 0.78 |
FOXO3 |
forkhead box O3 |
33777 |
0.22 |
chr13_36937386_36937669 | 0.78 |
SPG20 |
spastic paraplegia 20 (Troyer syndrome) |
6790 |
0.16 |
chr17_81092020_81092171 | 0.78 |
METRNL |
meteorin, glial cell differentiation regulator-like |
40101 |
0.18 |
chr9_80437599_80437890 | 0.78 |
GNAQ |
guanine nucleotide binding protein (G protein), q polypeptide |
171 |
0.98 |
chrX_13680096_13680380 | 0.78 |
TCEANC |
transcription elongation factor A (SII) N-terminal and central domain containing |
6824 |
0.2 |
chr4_165040749_165040900 | 0.78 |
MARCH1 |
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
264317 |
0.02 |
chr10_60779287_60779536 | 0.78 |
ENSG00000252076 |
. |
150467 |
0.04 |
chr5_14870333_14870900 | 0.77 |
ANKH |
ANKH inorganic pyrophosphate transport regulator |
1271 |
0.52 |
chr15_62862079_62862274 | 0.77 |
TLN2 |
talin 2 |
8612 |
0.27 |
chr8_103135084_103136044 | 0.77 |
NCALD |
neurocalcin delta |
614 |
0.72 |
chr17_59235229_59235413 | 0.77 |
RP11-136H19.1 |
|
21996 |
0.21 |
chr18_66290107_66290258 | 0.77 |
TMX3 |
thioredoxin-related transmembrane protein 3 |
92112 |
0.09 |
chr4_80544658_80545064 | 0.77 |
OR7E94P |
olfactory receptor, family 7, subfamily E, member 94 pseudogene |
35577 |
0.23 |
chr5_9284375_9284526 | 0.77 |
SEMA5A |
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
18793 |
0.26 |
chr6_81975145_81975342 | 0.77 |
RP1-300G12.2 |
|
269387 |
0.02 |
chr1_246948051_246948632 | 0.77 |
ENSG00000227953 |
. |
5585 |
0.17 |
chr3_114169976_114170457 | 0.77 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
3314 |
0.33 |
chr2_198702670_198703177 | 0.77 |
PLCL1 |
phospholipase C-like 1 |
27941 |
0.2 |
chr2_138709782_138709933 | 0.77 |
HNMT |
histamine N-methyltransferase |
11733 |
0.32 |
chrX_123094531_123095374 | 0.76 |
STAG2 |
stromal antigen 2 |
212 |
0.95 |
chr10_116063923_116064706 | 0.76 |
VWA2 |
von Willebrand factor A domain containing 2 |
65225 |
0.11 |
chr6_149802896_149803566 | 0.76 |
ZC3H12D |
zinc finger CCCH-type containing 12D |
1038 |
0.49 |
chr13_41012590_41012741 | 0.76 |
ENSG00000252812 |
. |
31088 |
0.23 |
chr16_72459040_72459191 | 0.76 |
ENSG00000207514 |
. |
48512 |
0.17 |
chr3_185741982_185742377 | 0.76 |
ENSG00000266670 |
. |
42096 |
0.14 |
chr3_187984581_187985052 | 0.76 |
LPP |
LIM domain containing preferred translocation partner in lipoma |
27164 |
0.24 |
chr11_131996154_131996587 | 0.76 |
RP11-697E14.2 |
|
141815 |
0.05 |
chr2_3642220_3642588 | 0.76 |
COLEC11 |
collectin sub-family member 11 |
141 |
0.93 |
chr8_11349538_11349737 | 0.75 |
BLK |
B lymphoid tyrosine kinase |
1873 |
0.29 |
chr5_81364650_81364809 | 0.75 |
ATG10-AS1 |
ATG10 antisense RNA 1 |
4792 |
0.23 |
chr2_159698320_159698471 | 0.75 |
OR7E89P |
olfactory receptor, family 7, subfamily E, member 89 pseudogene |
11872 |
0.19 |
chr9_36603313_36603464 | 0.75 |
MELK |
maternal embryonic leucine zipper kinase |
30480 |
0.23 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 4.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.9 | 2.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.9 | 2.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.9 | 3.5 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.8 | 3.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.7 | 1.5 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.7 | 0.7 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.7 | 2.7 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.7 | 2.0 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.6 | 2.4 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.6 | 1.7 | GO:0071692 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.5 | 1.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.5 | 1.0 | GO:0032656 | regulation of interleukin-13 production(GO:0032656) |
0.5 | 1.0 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.5 | 1.9 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.5 | 0.9 | GO:0021825 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.5 | 1.4 | GO:0060242 | contact inhibition(GO:0060242) |
0.5 | 0.5 | GO:2000318 | T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) T-helper 17 type immune response(GO:0072538) T-helper 17 cell differentiation(GO:0072539) T-helper 17 cell lineage commitment(GO:0072540) regulation of T-helper 17 type immune response(GO:2000316) positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 17 cell differentiation(GO:2000319) positive regulation of T-helper 17 cell differentiation(GO:2000321) regulation of T-helper 17 cell lineage commitment(GO:2000328) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.4 | 1.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.4 | 0.4 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.4 | 0.4 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.4 | 1.6 | GO:0001757 | somite specification(GO:0001757) |
0.4 | 1.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.4 | 0.8 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.4 | 0.8 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.4 | 1.5 | GO:0010761 | fibroblast migration(GO:0010761) |
0.4 | 1.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.4 | 1.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.4 | 1.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.4 | 1.1 | GO:1901339 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.4 | 1.5 | GO:0060992 | response to fungicide(GO:0060992) |
0.4 | 1.1 | GO:0008049 | male courtship behavior(GO:0008049) |
0.4 | 1.8 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.4 | 1.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 0.7 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.3 | 1.7 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.3 | 0.7 | GO:0007619 | courtship behavior(GO:0007619) |
0.3 | 0.3 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.3 | 1.4 | GO:0051665 | membrane raft localization(GO:0051665) |
0.3 | 1.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.3 | 0.3 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 0.7 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.3 | 1.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 1.0 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.3 | 0.6 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.3 | 2.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.3 | 1.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.3 | 0.6 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 0.9 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.3 | 0.9 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.3 | 1.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 0.9 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.3 | 0.9 | GO:0070932 | histone H3 deacetylation(GO:0070932) histone H4 deacetylation(GO:0070933) |
0.3 | 3.6 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.3 | 0.3 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.3 | 0.6 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.3 | 0.9 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 1.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 0.9 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.3 | 1.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.3 | 4.6 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.3 | 0.9 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.3 | 0.3 | GO:0070527 | platelet aggregation(GO:0070527) |
0.3 | 0.8 | GO:0002887 | negative regulation of myeloid leukocyte mediated immunity(GO:0002887) negative regulation of leukocyte degranulation(GO:0043301) |
0.3 | 5.8 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.3 | 0.8 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.3 | 1.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.3 | 0.8 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.3 | 0.3 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.3 | 0.8 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.3 | 0.5 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.3 | 0.8 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.2 | 1.0 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 0.7 | GO:0048840 | otolith development(GO:0048840) |
0.2 | 1.0 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.2 | 0.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 1.2 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.2 | 0.2 | GO:0061687 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.2 | 0.7 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.2 | 0.2 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.2 | 0.7 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 0.2 | GO:0010664 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.2 | 0.2 | GO:0090030 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) regulation of steroid hormone biosynthetic process(GO:0090030) |
0.2 | 2.5 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.2 | 0.7 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.2 | 1.8 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 0.7 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.2 | 0.5 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.2 | 1.6 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 0.7 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.2 | 0.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 1.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.2 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.2 | 0.9 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.4 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.2 | 0.4 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 0.9 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.6 | GO:0048935 | peripheral nervous system neuron development(GO:0048935) |
0.2 | 1.1 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.2 | 0.4 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.2 | 0.2 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 1.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.4 | GO:2000831 | corticosteroid hormone secretion(GO:0035930) regulation of steroid hormone secretion(GO:2000831) regulation of corticosteroid hormone secretion(GO:2000846) |
0.2 | 2.1 | GO:0007567 | parturition(GO:0007567) |
0.2 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 2.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.2 | 0.6 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 0.4 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 0.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 1.2 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.2 | 0.8 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.2 | 0.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.2 | 0.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.2 | 0.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 1.0 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.2 | 0.8 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 1.1 | GO:0044068 | modulation by virus of host process(GO:0019054) modulation by symbiont of host cellular process(GO:0044068) |
0.2 | 0.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 0.4 | GO:0003079 | obsolete positive regulation of natriuresis(GO:0003079) |
0.2 | 0.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.9 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 1.1 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 0.8 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 0.2 | GO:0072677 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
0.2 | 0.7 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.2 | 0.4 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.2 | 1.6 | GO:0032456 | endocytic recycling(GO:0032456) |
0.2 | 0.5 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 0.9 | GO:0043113 | receptor clustering(GO:0043113) |
0.2 | 0.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.4 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.2 | 0.9 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.2 | 0.4 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.2 | 0.5 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.2 | 2.3 | GO:0030325 | adrenal gland development(GO:0030325) |
0.2 | 0.5 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.9 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.2 | 0.3 | GO:0046101 | hypoxanthine biosynthetic process(GO:0046101) |
0.2 | 0.3 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.2 | 1.3 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 2.8 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.2 | 0.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 0.5 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
0.2 | 0.7 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.2 | 0.3 | GO:0032825 | regulation of natural killer cell differentiation(GO:0032823) positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 1.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.2 | 0.7 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 0.5 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.2 | 3.2 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.2 | 0.6 | GO:0006573 | valine metabolic process(GO:0006573) |
0.2 | 0.5 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.2 | 1.0 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.2 | 0.2 | GO:0060073 | urinary bladder smooth muscle contraction(GO:0014832) micturition(GO:0060073) smooth muscle contraction involved in micturition(GO:0060083) |
0.2 | 0.5 | GO:0070828 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.2 | 0.5 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.2 | 0.3 | GO:1903306 | negative regulation of regulated secretory pathway(GO:1903306) |
0.2 | 0.5 | GO:0003207 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.2 | 0.8 | GO:0032653 | regulation of interleukin-10 production(GO:0032653) |
0.2 | 0.6 | GO:0007494 | midgut development(GO:0007494) |
0.2 | 0.5 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 0.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.2 | 1.2 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.2 | 0.9 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.2 | 0.5 | GO:0052257 | pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response(GO:0052033) positive regulation by symbiont of host innate immune response(GO:0052166) modulation by symbiont of host innate immune response(GO:0052167) pathogen-associated molecular pattern dependent modulation by symbiont of host innate immune response(GO:0052169) pathogen-associated molecular pattern dependent induction by organism of innate immune response of other organism involved in symbiotic interaction(GO:0052257) positive regulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052305) modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052306) pathogen-associated molecular pattern dependent modulation by organism of innate immune response in other organism involved in symbiotic interaction(GO:0052308) |
0.2 | 0.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.2 | 0.5 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 0.2 | GO:2000644 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.1 | 3.6 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.1 | 0.7 | GO:0042977 | activation of JAK2 kinase activity(GO:0042977) |
0.1 | 0.4 | GO:0044321 | cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
0.1 | 0.6 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.3 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) semicircular canal development(GO:0060872) |
0.1 | 0.3 | GO:1903054 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.6 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.8 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 | 0.3 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.6 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.1 | 0.8 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.3 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.1 | 0.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) |
0.1 | 0.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.1 | 0.5 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.5 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.9 | GO:0043368 | positive T cell selection(GO:0043368) |
0.1 | 0.3 | GO:0009265 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) 2'-deoxyribonucleotide biosynthetic process(GO:0009265) deoxyribose phosphate biosynthetic process(GO:0046385) |
0.1 | 0.8 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.1 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.1 | 0.4 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.1 | 0.4 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.3 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 0.5 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.1 | 0.7 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.4 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.9 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.1 | 0.3 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.5 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 1.9 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.4 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.5 | GO:0014866 | skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.6 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.1 | 0.2 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.1 | 0.6 | GO:0048857 | neural nucleus development(GO:0048857) |
0.1 | 0.1 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.6 | GO:0061384 | heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
0.1 | 0.4 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.6 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.1 | 0.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.9 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.1 | 0.7 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.3 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 5.7 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.1 | 2.3 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.2 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.1 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.1 | 0.5 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.1 | 0.1 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.1 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 2.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.1 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 0.8 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 0.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.3 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.4 | GO:0051597 | response to methylmercury(GO:0051597) |
0.1 | 0.4 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.1 | 0.4 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.1 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.1 | 0.4 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 1.0 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.3 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.1 | 0.2 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.1 | 0.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.2 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.7 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.1 | 0.6 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.2 | GO:0060592 | mammary gland formation(GO:0060592) |
0.1 | 0.2 | GO:0032515 | negative regulation of phosphatase activity(GO:0010923) negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.5 | GO:0007143 | female meiotic division(GO:0007143) |
0.1 | 0.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.3 | GO:0031340 | regulation of vesicle fusion(GO:0031338) positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.3 | GO:0000470 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.2 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.1 | 0.1 | GO:0098900 | regulation of action potential(GO:0098900) |
0.1 | 0.3 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.2 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.3 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.3 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 0.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.1 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.1 | 0.2 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.3 | GO:0046668 | retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 0.6 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.3 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.4 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 1.0 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.1 | GO:0060413 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.1 | 1.5 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.1 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 0.2 | GO:0072070 | loop of Henle development(GO:0072070) |
0.1 | 0.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.1 | 0.3 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.1 | 0.3 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 2.6 | GO:0001764 | neuron migration(GO:0001764) |
0.1 | 0.2 | GO:0048557 | embryonic digestive tract morphogenesis(GO:0048557) |
0.1 | 0.5 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.5 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.1 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.1 | 0.3 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 1.1 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
0.1 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.1 | 0.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.5 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.1 | 0.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.1 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.2 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.1 | 0.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.1 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.1 | 0.1 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.7 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.4 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.1 | 0.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.1 | 0.2 | GO:1903427 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of reactive oxygen species biosynthetic process(GO:1903427) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.1 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.1 | GO:0014034 | neural crest formation(GO:0014029) neural crest cell fate commitment(GO:0014034) |
0.1 | 0.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 0.3 | GO:0042117 | monocyte activation(GO:0042117) |
0.1 | 0.5 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.1 | 0.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.1 | GO:2000108 | positive regulation of lymphocyte apoptotic process(GO:0070230) positive regulation of leukocyte apoptotic process(GO:2000108) |
0.1 | 0.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.5 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.1 | 0.1 | GO:1904376 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.3 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.1 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.1 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.4 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.1 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.1 | 0.3 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.1 | 0.3 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.1 | GO:0036336 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.1 | 0.2 | GO:0051957 | positive regulation of glutamate secretion(GO:0014049) positive regulation of amino acid transport(GO:0051957) |
0.1 | 0.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.1 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 0.1 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.1 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.1 | 0.2 | GO:0042745 | circadian sleep/wake cycle(GO:0042745) |
0.1 | 0.6 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 0.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) protein side chain deglutamylation(GO:0035610) |
0.1 | 0.1 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.1 | 0.1 | GO:0071504 | cellular response to heparin(GO:0071504) |
0.1 | 0.6 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.1 | 0.1 | GO:1901798 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.3 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.5 | GO:1902749 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.1 | 0.1 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.1 | 0.2 | GO:0002040 | sprouting angiogenesis(GO:0002040) |
0.1 | 0.1 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.1 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
0.1 | 0.1 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.1 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.1 | 0.2 | GO:0051963 | regulation of synapse assembly(GO:0051963) |
0.1 | 0.1 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.1 | 0.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 0.2 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.2 | GO:0090026 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.1 | GO:0015904 | tetracycline transport(GO:0015904) |
0.1 | 0.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.4 | GO:0090398 | cellular senescence(GO:0090398) |
0.1 | 0.1 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.1 | 0.2 | GO:0006531 | aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
0.1 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.2 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.2 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.1 | GO:0010823 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.1 | 0.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.2 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) |
0.1 | 0.2 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.1 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.1 | 0.2 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.2 | GO:0014904 | myotube cell development(GO:0014904) skeletal muscle fiber development(GO:0048741) |
0.1 | 0.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.5 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.2 | GO:0043474 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.1 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.2 | GO:1903393 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
0.1 | 0.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.1 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 0.4 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.4 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.1 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.2 | GO:0045329 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.1 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.1 | GO:0007063 | regulation of sister chromatid cohesion(GO:0007063) |
0.0 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.1 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.0 | 0.2 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.1 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.0 | 0.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.1 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.0 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.0 | GO:0009111 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.2 | GO:0032372 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.0 | 0.1 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.1 | GO:0050974 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 0.3 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.0 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.0 | 0.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.4 | GO:0051057 | positive regulation of Ras protein signal transduction(GO:0046579) positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.0 | 0.1 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
0.0 | 0.2 | GO:0071599 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.3 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.0 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.0 | 0.1 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.4 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.0 | 0.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.0 | 0.3 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.0 | 0.0 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.0 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.0 | 0.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.0 | 0.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.3 | GO:1901072 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.1 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.0 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.3 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.2 | GO:0015840 | urea transport(GO:0015840) |
0.0 | 0.2 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.0 | 0.0 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.1 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.0 | 0.2 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 1.0 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.0 | 0.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.3 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.1 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.0 | 0.3 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 1.2 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) regulation of phospholipase C activity(GO:1900274) |
0.0 | 1.0 | GO:0007272 | ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) |
0.0 | 0.1 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.1 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.2 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.1 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.0 | 0.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.0 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.0 | 0.0 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.0 | 0.0 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.2 | GO:0050812 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.0 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.0 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.0 | 0.1 | GO:0009437 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.0 | 0.0 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.0 | GO:0070471 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.0 | 0.6 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.1 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.0 | 0.1 | GO:0009261 | purine ribonucleotide catabolic process(GO:0009154) ribonucleotide catabolic process(GO:0009261) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.0 | 0.0 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.0 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.0 | 0.0 | GO:0010939 | regulation of necrotic cell death(GO:0010939) |
0.0 | 0.0 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:1901019 | regulation of calcium ion transmembrane transporter activity(GO:1901019) regulation of cation channel activity(GO:2001257) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.1 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.0 | 0.0 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.0 | 0.0 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.0 | 0.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.2 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.1 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.0 | 0.1 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
0.0 | 0.5 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.2 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 0.2 | GO:0044409 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.0 | 0.1 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.2 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.1 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.0 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.1 | GO:0010171 | body morphogenesis(GO:0010171) |
0.0 | 0.0 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.0 | 0.0 | GO:0070265 | necrotic cell death(GO:0070265) |
0.0 | 0.1 | GO:0009071 | glycine catabolic process(GO:0006546) serine family amino acid catabolic process(GO:0009071) |
0.0 | 0.0 | GO:0070091 | glucagon secretion(GO:0070091) |
0.0 | 0.0 | GO:0072170 | metanephric tubule development(GO:0072170) metanephric epithelium development(GO:0072207) |
0.0 | 0.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.1 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.0 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.1 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
0.0 | 0.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.1 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.0 | 0.1 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.4 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.1 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.0 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.0 | 0.0 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.0 | 0.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.0 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.0 | 0.1 | GO:0007530 | sex determination(GO:0007530) |
0.0 | 0.1 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.1 | GO:0055069 | cellular zinc ion homeostasis(GO:0006882) zinc ion homeostasis(GO:0055069) |
0.0 | 0.1 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.0 | 0.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.0 | 0.0 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.3 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.1 | GO:0001662 | behavioral fear response(GO:0001662) |
0.0 | 0.2 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.0 | 0.0 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.0 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.0 | 0.0 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.0 | 0.1 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.0 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.0 | 0.2 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 | 0.0 | GO:0000154 | rRNA modification(GO:0000154) rRNA methylation(GO:0031167) |
0.0 | 0.3 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.0 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 0.1 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
0.0 | 0.3 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.1 | GO:0010669 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.0 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.0 | GO:0034651 | cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
0.0 | 0.1 | GO:0060348 | bone development(GO:0060348) |
0.0 | 0.0 | GO:0031427 | response to methotrexate(GO:0031427) |
0.0 | 0.0 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.0 | 0.1 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.0 | 0.1 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.1 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.0 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.0 | 0.0 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.1 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.0 | GO:0045056 | transcytosis(GO:0045056) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.3 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.6 | 7.1 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.5 | 1.6 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.4 | 3.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.4 | 1.6 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.4 | 0.4 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 1.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 1.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 1.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.3 | 1.0 | GO:0033646 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.3 | 1.8 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.3 | 1.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 3.5 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.3 | 1.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 0.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.3 | 0.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.3 | 0.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 0.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 1.5 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.2 | 0.9 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.2 | 1.9 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.4 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 1.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 0.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.8 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 1.0 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 6.4 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 0.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 2.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 0.9 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.2 | 1.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 0.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 0.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 0.6 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.2 | 0.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.3 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 0.9 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 3.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.4 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 0.4 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.1 | 0.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 1.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.4 | GO:0044304 | main axon(GO:0044304) |
0.1 | 0.4 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.1 | 1.1 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 3.4 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 5.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 3.8 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.1 | 0.8 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.3 | GO:0042597 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.1 | 0.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.2 | GO:0031904 | endosome lumen(GO:0031904) |
0.1 | 0.6 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.5 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.5 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 1.0 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.9 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.6 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 1.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 1.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.1 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 1.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.2 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.3 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 2.6 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.7 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.6 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 1.0 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.4 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 1.1 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 6.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.5 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 2.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.8 | GO:0033267 | axon part(GO:0033267) |
0.0 | 0.2 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 0.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.6 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.0 | 0.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.3 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 9.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.2 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.3 | GO:0032156 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.0 | 0.0 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 0.6 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 2.7 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 2.4 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.0 | 2.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.2 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.0 | 0.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0031674 | I band(GO:0031674) |
0.0 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.0 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 1.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.0 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.6 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 1.2 | GO:0044441 | ciliary part(GO:0044441) |
0.0 | 0.0 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.0 | 0.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.2 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 3.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.5 | 1.5 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.5 | 1.5 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.5 | 1.4 | GO:0070052 | collagen V binding(GO:0070052) |
0.5 | 4.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 1.8 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.4 | 0.4 | GO:0043559 | insulin binding(GO:0043559) |
0.4 | 2.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.4 | 1.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.4 | 3.0 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.4 | 1.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 1.6 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.3 | 1.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 0.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 2.7 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.3 | 2.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 0.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 3.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.3 | 2.8 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 9.7 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 0.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 0.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 1.0 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.3 | 0.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 0.8 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.3 | 0.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 0.7 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 1.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.2 | 0.7 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 1.9 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.2 | 0.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 0.9 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 0.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 1.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 1.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 1.3 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.2 | 0.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 0.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 2.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 0.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 0.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 0.4 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 0.8 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.2 | 2.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 0.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.6 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.2 | 1.6 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 0.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 1.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.2 | 0.6 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.7 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.2 | 2.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 0.7 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 0.7 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.2 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.4 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 0.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 0.5 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 0.5 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 0.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 0.5 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.2 | 1.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.5 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.2 | 1.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 0.5 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 0.5 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 0.3 | GO:0032558 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.2 | 0.6 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 1.8 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 1.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 1.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 0.8 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.2 | 0.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 1.4 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.2 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.4 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
0.1 | 1.3 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.7 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.4 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 0.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.4 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.7 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.4 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.1 | 0.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.6 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.1 | 0.9 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.4 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.5 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 1.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.5 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 0.5 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 1.6 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 1.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.7 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 1.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.4 | GO:0097493 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.5 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
0.1 | 0.9 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.1 | 0.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 1.3 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 1.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.3 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 4.5 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.1 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.2 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.1 | 5.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.5 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 6.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 1.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.6 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 1.0 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 1.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.5 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 0.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 1.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.6 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.1 | 1.1 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.1 | 0.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.1 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 1.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 1.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 1.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 1.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 2.0 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 1.5 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.1 | 0.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.2 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.1 | 1.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 2.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.2 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.3 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.1 | 0.2 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.1 | 0.3 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 1.1 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.3 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.1 | 0.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.4 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.3 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 0.1 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.2 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.1 | 0.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.1 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.1 | 0.2 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 0.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.1 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.1 | 0.1 | GO:0043176 | amine binding(GO:0043176) |
0.1 | 0.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.8 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.1 | 1.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.3 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.7 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 0.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.3 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.2 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.2 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.1 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.4 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.0 | 0.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.3 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.0 | 0.4 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.0 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.5 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.0 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 1.8 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 1.3 | GO:0019825 | oxygen binding(GO:0019825) |
0.0 | 0.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 1.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.0 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.0 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.3 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.7 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.3 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.2 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 0.6 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.4 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.3 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.1 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.0 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 1.3 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.3 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.0 | 0.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.2 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.2 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 8.7 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.8 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.0 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.0 | 0.9 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.0 | 0.1 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.2 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.0 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.3 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.2 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.0 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.2 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.0 | 0.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.0 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.6 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 1.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.2 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.0 | GO:0005035 | death receptor activity(GO:0005035) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0001228 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.0 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.9 | GO:0022843 | voltage-gated cation channel activity(GO:0022843) |
0.0 | 0.2 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 0.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.0 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.3 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 4.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 10.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 8.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 0.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 0.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 6.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 1.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 1.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 2.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 5.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 6.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 1.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 0.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 2.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 14.1 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.1 | 1.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 2.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 2.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.1 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 0.3 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.9 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 1.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.8 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.4 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 1.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 1.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 3.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.3 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 6.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.4 | 1.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 2.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.3 | 3.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 3.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.3 | 3.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 2.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 2.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 3.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.2 | 0.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 1.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 4.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 4.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 2.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 2.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 1.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 1.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 1.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 5.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 1.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 0.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 1.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 2.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 2.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 2.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.5 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 3.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.3 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 0.8 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 2.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 1.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 3.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 1.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 3.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 1.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.4 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.1 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 0.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.4 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 0.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 1.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 0.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.8 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.1 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 1.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 0.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 0.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.1 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.1 | 0.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 0.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 0.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.7 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 0.8 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
0.1 | 0.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 1.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 1.0 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 0.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.9 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 3.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.2 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.3 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.0 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |